Clinical Trial Update: Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 vaccine therapy trial for unresected stage III/IV melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED